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RAPPORT DE SYNTHESE 
La maladie de Coats est une vasculopathie non héréditaire. Elle est caractérisée par la 
présence de télangiectasies rétiniennes idiopathiques, d'exsudats lipidiques 
intrarétiniens et sousrétiniens, une rétinopathie ischémique et un décollement de rétine 
exsudative. Cette maladie se présente typiquement dans l'enfance, elle est unilatérale et 
atteint les hommes dans la majorité des cas. Nous décrivons un cas atypique d'un patient 
avec une maladie de Coats qui a récidivé 30 ans plus tard malgré un traitement initial 
efficace. Ce cas illustre l'évolution de la maladie de Coats à long terme. 
L'enjeu de ce cas est de faire une étude exhaustive des différents traitements possibles 
de cette maladie. 
Nous avons réalisé une révision de la littérature des cas de la maladie de Coats qui ont 
récidivé à long terme. Il y a peu de cas décrits dans la littérature avec un long suivi. 
En conclusion, la maladie de Coats doit être considérée comme une maladie chronique 
qui nécessite un suivi à long terme. Cette maladie peut se réveiller et récidiver dans des 
zones de la rétine, qui n'ont pas été atteintes auparavant, et plusieures décennies plus 
tard. 
Le traitement standard de cette maladie est la réalisation d'une cryothérapie et du laser 
argon dans les zones atteintes de la rétine. Dans les cas où l'exsudation rétinienne est 
très importante il peut s'avérer de faire un traitement chirurgical avec drainage du 
liquide sousrétinien, ce qui a été réalisé sur ce patient. 
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CASE REPORT 
Reemergence of dormant Coats disease after 30 
years 
Eric Pérez-Campagne, Thomas J. Wolfensberger 
Hôpital Ophtalmique Jules Gonin, Université de Lausanne, Lausanne - Switzerland 
PuRPOSE. We describe an atypical case of a patient with Coats disease that re-emerged after 30 years, 
il/ustrating a previously poorly understood /ong-term evolution of the disease. 
METHoos. A 20-year-old man consulted for visual acuity (VA) decrease in the left eye (LE) to 0.3. Fundus 
examination revealed an exudative lesion with telangiectasias in the superior peripheral retina compa-
tible with the diagnosis of Coats disease. 
RESULTS. The patient was treated with cryotherapy and argon laser. Visual acuity improved to 0.5 and 
remained stable during a 1-year fo//ow-up. The patient did not seek further clinical follow-up. Thirty 
years later, he returned complaining of a progressive VA decrease in the LE. Sne//en VA was measured 
to counting fingers. Fundus examination revealed stage 3A Coats disease with maculer exudation and 
a serous retinal detachment in the inferior quadrants requiring the placement of an encircling band, 
externat drainage, and cryotherapy of the vascu/ar /esions. After 10 additional sessions of argon laser 
on the vascular malformations, exudation regressed further and best-corrected VA increased to O. 1 at 
the end of the fo/low-up period. 
CoNcLus10Ns. Coats disease must be considered as a chronic disease, which necessitates a very long-
term fo//ow-up even in the absence of subjective visual loss. The disease can reawaken and recur with 
force in previously unaffected areas of the retina several decades later. The gold standard treatment 
consists of cryotherapy and argon laser. However, in cases of very important retinal exudation, surgical 
management with subretinal drainage may be necessary. 
KEY WoRos. Coats disease, Cryotherapy, Exudative retina/ detachment, /ntraretinal and subretinal 
lipidic exudates, Laser photocoagulation, Retinal telangiectases 
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INTRODUCTION 
Coats disease is a non-hereditary vasculopathy charac-
terized by idiopathie retinal telangiectases, intraretinal 
and subretinal lipidic exudates, ischemic retinopathy, 
and exudative retinal detachment (1 ). Coats disease 
typically presents in early childhood with vision loss, 
strabismus, or leukocoria. lt usually occurs unilaterally 
in males (1). We describe an atypical case of a patient 
with Coats disease that illustrates the evolution of the 
disease over a 30-year period. 
Case report 
A 20-year-old man presented for the first time to our de-
partment in 1975 due to graduai visual loss. The ophthal-
mic exam1nation of his right eye (RE) was normal. The 
left eye (LE) had a best-corrected visual acuity 0/A) of 0.3 
(-1.0/180°). Biomicroscopy showed no inflammation of the 
anterior segment and a normal intraocular pressure (IOP). 
On fundus examination, an exudative lesion with telangie-
ctases could be seen in the superior peripheral retina and 
the diagnosis of Coats disease was made {Fig. 1, A-D). The 
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Fig. 1 - (A) Fundus photograph at age 20 years showing peripapillary and macular exudates ln the form of a macular star. (B) Peripheral 
exudates in the periphera/ super/or retfna accompanied by hemorrhages and vascular telang/ectases. (C) F/uorescein angiography showing 
capillary nonperfusion, telangiectases, and vascular malformations with hyperfluorescent aneurysmal dilatations. (D) ln the end stages of the 
angiogram, cystoid macu/ar edema accompanied by exudation in the peripapillary region and throughout the temporal inferior arcade can be 
seen. There were no untoward s/gns of exudation on the fluorescein angiography in the inferior fundus. (E, F) Fundus photography 6 months 
after the initial treatment with cryotherapy and argon laser. (E) Note the diminished exudates in the peripapil/ary and macular area. (F) Clca-
tricial chorioretinal scars in the superior quadrants wit/1 disappearance of the retinal exudation. 
exudative lesion was treated with cryotherapy and argon 
laser. Six months after the treatment, VA improved to 0.5, 
remaining stable during the ensuing year (Fig. 1, E, F). The 
patient was then lost to follow-up and, since VA remained 
stable, did not seek further medical help for the next 29 
years. 
Thirty years after the initial treatment, the patient returned 
to our department as he had a progressive loss of VA in 
his LE for about 1 month. The ophthalmic examination of 
the RE was normal, but VA of the LE had diminished to fin-
ger counting at 1 meter. Anterior segment biomicroscopy 
and IOP were normal. Fundus slit-lamp examination sho-
wed a retinal detachment in the inferior retina associated 
with marked peripapillary and macular exudation as well 
as typical peripheral areas with telangiectases and other 
vascular malformations compatible with stage 3A of Coats 
disease (Fig 2, A-D) (1). At that time, the retinal detachment 
was considered of serous origin, but due to the presence 
of an area of lattice degeneration with a possible small re-
tinal dehiscence in the temporal detached retina, the diffe-
rential diagnosis of a rhegmatogenous retinal detachment 
was retained as well. 
Fluorescein angiography confirmed the presence of typi-
cal peripheral telangiectases as well as cystoid macular 
edema (Fig. 2E). The retinal detachment was treated with 
a silicone 240 encircling band (Labtician, Oakville, Onta-
rio, Canada) placed under the 4 rectus muscles and fixed 
with a braided nonresorbable suture in all 4 quadrants. ln 
addition, cryocoagulation and external drainage were per-
formed, as the vascular malformations could not be tre-
ated otherwise due to the bullous detachment. Once the 
retina was attached peroperatively, cryotherapy could then 
be applied in the areas of vascular malformation. No reti-
nal tear could be documented during surgery. At 2 months 
postoperatively, optical coherence tomography (OCT) did 
not show overt cystoid macular edema but only a diffuse 
thickening of the macula (Fig. 3A). During the 12 months 
after surgery the patient underwent 1 O sessions of additio-
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Fig. 2 - (A} Pictorial diagram of the ratinai changes at presentation 30 years after the first treatment. Note the large areas of exudation as we/I 
as the retinal detachment in the inferior retina. (B} Fundus photography showing new peripapillary and macular exudates with signs of retlnal 
detachment inferiorly. (C) Massive intraretinal and subretinal lipidic exudates in the nasal retlna with areas of telangiectasia in the periphery. 
(D) The chorioretlnal scars in the superior quadrant are due to the Initial treatment of cryotherapy and argon laser 30 years previously. (E} 
Fluorescein angiography showing the cicatricial peripheral superior retina without major leakage. The peripapillary and macular hypofluore-
scence corresponds to a blocking effect by the exudates. The nasal, inferior, and temporal hyperf/uorescence corresponds to leakage from 
the typical telangiectases of Coats disease. 
Fig. 3 - (A} Optical coherence tomography of the foveolar area 2 months after retinal detachment surgery, which included external drainage 
of the subretinal fluid and cryocoagulation. On/y diffuse macular edema can be seen. (B) Fundus photograph 12 months after the retinal de-
tachment surgery and repeated laser application on the residual areas of telangiectases. Note the regression of the peripapi/lary and macular 
exudates. (C} Fundus photograph taken at the same time showing fibrosis both of the retina and retinal vessais in the temporal peripheral 
retina. (D} Composite images of the fluorescein angiography showing exudates in the nasal, inferior, and temporal retina. There is residua/ 
diffuse leakage in the macula although no frank cystoid edema can be seen. Note the laser scars in the periphery of the lower quadrants with 
a marked decrease of the leakage of the vascular ma/formations. 
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nal argon laser treatment in the areas of persistent vascular 
malformations, which had caused continuing exudation. 
With time an almost complete attachment of the retina was 
achieved, which was associated with a minimal residual 
amount of retinal exudates (Fig. 3, 8-D). Best-corrected VA 
at the end of the follow-up period was 0.1 (+2 -2.5 x180°). 
DISCUSSION 
The present case is instructive as it depicts a previously 
poorly understood long-term evolution of Coats disease 
over a 30-year period. lt is remarkable that even though a 
small telangiectatic retinal lesion was treated successfully, 
the disease could nevertheless reawaken and recur with 
force in previously unaffected retina several decades later. 
The mechanisms behind this late re-emergence of Coats 
disease are not well understood (2). 
The first manifestation of the disease was successfully trea-
ted with simple cryotherapy and laser on the affected retinal 
areas. This comblnation treatment has remained the gold 
standard if there is little subretinal liquid (3). As the clinical 
manifestations of the second episode of the disease were 
complicated by a bullous inferior serous retinal detachment 
due to the marked exudation, drainage of the subretinal flu-
id and placement of an encircling band became necessary 
to reattach the retina to the retinal pigment epithelium, thus 
permitting subsequent cryotherapy or laser treatment. 
ln many cases it is essential to apply postsurgical argon 
laser in several sessions on areas of persisting vascular 
malformations. This can be performed even in a slightly 
detached retina, but it is advisable to employ energies of 
about 500 mW with a duration of 1000 milliseconds in ordêr 
to coagulate the malformations completely. Recently, laser 
has also been used successfully with adjunct medical the-
rapy such as intravitreal corticosteroids and other growth 
factor inhibitors (4). More invasive intravitreal surgery may 
become indispensable if persisting exudation triggers re-
tinal detachment or the formation of important epiretinal 
membranes (5, 6). 
ln conclusion, the present case underlines the fact that it 
is possible for the disease to recur after several decades 
even if the initial lesions were treated successfully. The re-
emergence of the disease can occur in previously unaf-
fected areas of the retina. Coats disease must therefore 
be considered as a chronic disease, which necessitates a 
very long-term follow-up even in the absence of subjective 
visual loss (2, 7). 
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